Global Adrenocortical Carcinoma Treatment Market Research Report 2023

Report ID: 1989418 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Localized Adrenocortical Carcinoma
        1.2.3 Metastatic Adrenocortical Carcinoma
    1.3 Market by Application
        1.3.1 Global Adrenocortical Carcinoma Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Clinics
        1.3.5 Cancer Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Adrenocortical Carcinoma Treatment Market Perspective (2017-2028)
    2.2 Adrenocortical Carcinoma Treatment Growth Trends by Region
        2.2.1 Adrenocortical Carcinoma Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Adrenocortical Carcinoma Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Adrenocortical Carcinoma Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Adrenocortical Carcinoma Treatment Market Dynamics
        2.3.1 Adrenocortical Carcinoma Treatment Industry Trends
        2.3.2 Adrenocortical Carcinoma Treatment Market Drivers
        2.3.3 Adrenocortical Carcinoma Treatment Market Challenges
        2.3.4 Adrenocortical Carcinoma Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue
        3.1.1 Global Top Adrenocortical Carcinoma Treatment Players by Revenue (2017-2022)
        3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Adrenocortical Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Adrenocortical Carcinoma Treatment Revenue
    3.4 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio
        3.4.1 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Adrenocortical Carcinoma Treatment Revenue in 2021
    3.5 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
    3.6 Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
    3.7 Date of Enter into Adrenocortical Carcinoma Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Adrenocortical Carcinoma Treatment Breakdown Data by Type
    4.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2023-2028)
5 Adrenocortical Carcinoma Treatment Breakdown Data by Application
    5.1 Global Adrenocortical Carcinoma Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Adrenocortical Carcinoma Treatment Market Size (2017-2028)
    6.2 North America Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022)
    6.3 North America Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Adrenocortical Carcinoma Treatment Market Size (2017-2028)
    7.2 Europe Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022)
    7.3 Europe Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Adrenocortical Carcinoma Treatment Market Size (2017-2028)
    9.2 Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022)
    9.3 Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 ArQule
        11.1.1 ArQule Company Detail
        11.1.2 ArQule Business Overview
        11.1.3 ArQule Adrenocortical Carcinoma Treatment Introduction
        11.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022)
        11.1.5 ArQule Recent Development
    11.2 EnGeneIC
        11.2.1 EnGeneIC Company Detail
        11.2.2 EnGeneIC Business Overview
        11.2.3 EnGeneIC Adrenocortical Carcinoma Treatment Introduction
        11.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022)
        11.2.5 EnGeneIC Recent Development
    11.3 Exelixis
        11.3.1 Exelixis Company Detail
        11.3.2 Exelixis Business Overview
        11.3.3 Exelixis Adrenocortical Carcinoma Treatment Introduction
        11.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022)
        11.3.5 Exelixis Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Adrenocortical Carcinoma Treatment Introduction
        11.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Millendo Therapeutics
        11.5.1 Millendo Therapeutics Company Detail
        11.5.2 Millendo Therapeutics Business Overview
        11.5.3 Millendo Therapeutics Adrenocortical Carcinoma Treatment Introduction
        11.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022)
        11.5.5 Millendo Therapeutics Recent Development
    11.6 Orphagen Pharmaceuticals
        11.6.1 Orphagen Pharmaceuticals Company Detail
        11.6.2 Orphagen Pharmaceuticals Business Overview
        11.6.3 Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Introduction
        11.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022)
        11.6.5 Orphagen Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Localized Adrenocortical Carcinoma
    Table 3. Key Players of Metastatic Adrenocortical Carcinoma
    Table 4. Global Adrenocortical Carcinoma Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Adrenocortical Carcinoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Adrenocortical Carcinoma Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Adrenocortical Carcinoma Treatment Market Share by Region (2017-2022)
    Table 8. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Adrenocortical Carcinoma Treatment Market Share by Region (2023-2028)
    Table 10. Adrenocortical Carcinoma Treatment Market Trends
    Table 11. Adrenocortical Carcinoma Treatment Market Drivers
    Table 12. Adrenocortical Carcinoma Treatment Market Challenges
    Table 13. Adrenocortical Carcinoma Treatment Market Restraints
    Table 14. Global Adrenocortical Carcinoma Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Adrenocortical Carcinoma Treatment Market Share by Players (2017-2022)
    Table 16. Global Top Adrenocortical Carcinoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Carcinoma Treatment as of 2021)
    Table 17. Ranking of Global Top Adrenocortical Carcinoma Treatment Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Adrenocortical Carcinoma Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Adrenocortical Carcinoma Treatment Product Solution and Service
    Table 21. Date of Enter into Adrenocortical Carcinoma Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Adrenocortical Carcinoma Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2017-2022)
    Table 25. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Type (2023-2028)
    Table 27. Global Adrenocortical Carcinoma Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Application (2017-2022)
    Table 29. Global Adrenocortical Carcinoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Adrenocortical Carcinoma Treatment Revenue Market Share by Application (2023-2028)
    Table 31. North America Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. ArQule Company Detail
    Table 42. ArQule Business Overview
    Table 43. ArQule Adrenocortical Carcinoma Treatment Product
    Table 44. ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022) & (US$ Million)
    Table 45. ArQule Recent Development
    Table 46. EnGeneIC Company Detail
    Table 47. EnGeneIC Business Overview
    Table 48. EnGeneIC Adrenocortical Carcinoma Treatment Product
    Table 49. EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022) & (US$ Million)
    Table 50. EnGeneIC Recent Development
    Table 51. Exelixis Company Detail
    Table 52. Exelixis Business Overview
    Table 53. Exelixis Adrenocortical Carcinoma Treatment Product
    Table 54. Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022) & (US$ Million)
    Table 55. Exelixis Recent Development
    Table 56. Merck Company Detail
    Table 57. Merck Business Overview
    Table 58. Merck Adrenocortical Carcinoma Treatment Product
    Table 59. Merck Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022) & (US$ Million)
    Table 60. Merck Recent Development
    Table 61. Millendo Therapeutics Company Detail
    Table 62. Millendo Therapeutics Business Overview
    Table 63. Millendo Therapeutics Adrenocortical Carcinoma Treatment Product
    Table 64. Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022) & (US$ Million)
    Table 65. Millendo Therapeutics Recent Development
    Table 66. Orphagen Pharmaceuticals Company Detail
    Table 67. Orphagen Pharmaceuticals Business Overview
    Table 68. Orphagen Pharmaceuticals Adrenocortical Carcinoma Treatment Product
    Table 69. Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2017-2022) & (US$ Million)
    Table 70. Orphagen Pharmaceuticals Recent Development
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Adrenocortical Carcinoma Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Localized Adrenocortical Carcinoma Features
    Figure 3. Metastatic Adrenocortical Carcinoma Features
    Figure 4. Global Adrenocortical Carcinoma Treatment Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Ambulatory Surgical Centers Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Cancer Research Institutes Case Studies
    Figure 9. Adrenocortical Carcinoma Treatment Report Years Considered
    Figure 10. Global Adrenocortical Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Adrenocortical Carcinoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Adrenocortical Carcinoma Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Adrenocortical Carcinoma Treatment Market Share by Players in 2021
    Figure 14. Global Top Adrenocortical Carcinoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Carcinoma Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Adrenocortical Carcinoma Treatment Revenue in 2021
    Figure 16. North America Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Adrenocortical Carcinoma Treatment Market Share by Country (2017-2028)
    Figure 18. United States Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Adrenocortical Carcinoma Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Adrenocortical Carcinoma Treatment Market Share by Region (2017-2028)
    Figure 30. China Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Adrenocortical Carcinoma Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Adrenocortical Carcinoma Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Adrenocortical Carcinoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. ArQule Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2017-2022)
    Figure 45. EnGeneIC Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2017-2022)
    Figure 46. Exelixis Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2017-2022)
    Figure 47. Merck Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2017-2022)
    Figure 48. Millendo Therapeutics Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2017-2022)
    Figure 49. Orphagen Pharmaceuticals Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2017-2022)
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals
Frequently Asked Questions
Adrenocortical Carcinoma Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Adrenocortical Carcinoma Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Adrenocortical Carcinoma Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

ADS-B

ADS-B market is segmented by players, region (country), by Type and by Application. Players, stak ... Read More